Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FSZ48
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $122,843
Award facts
- Contract value 100% obligated
- $122,843.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $122.8K for Keytruda 100 mg/4 ml vials. The award, issued on August 29, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500M single-award vehicle valid through November 2026 that enables the agency to procure an extensive portfolio of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's pharmaceutical distribution capabilities span oncology treatments, vaccines, specialty medications, and other essential medical products. As a woman-owned small business registered in SAM.gov since 2001, DMS Pharmaceutical Group has leveraged its status to compete effectively in federal procurement markets while maintaining a robust contract portfolio with DLA covering diverse therapeutic categories and delivery requirements across military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FSZ48?
SPE2DB25FSZ48 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FSZ48 worth?
The government has obligated $122,843 on SPE2DB25FSZ48.
Is contract SPE2DB25FSZ48 an order under another contract?
Yes. SPE2DB25FSZ48 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ48 competed?
The extent of competition for SPE2DB25FSZ48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award